Review Article
Recent Advances on Pathophysiology, Diagnostic and Therapeutic Insights in Cardiac Dysfunction Induced by Antineoplastic Drugs
Table 1
Current insights in prevention, monitoring and treatment of cardiac dysfunction induced by anticancer drugs. Modified from [
102].
| Prevention | Monitoring | Treatment |
| Alternative anticancer strategies Reduced chemotherapeutic dose Liposomal formulations Less toxic alternatives (epirubicin, lapatinib) Better patients selection Age Cardiac risk Cardiac function Use of cardioprotective drugs β-blockers ACE inhibitors ARBs Dexrazoxane Statins | Imaging Assess the best modality Assess the best frequency Biomarkers BNP Troponins Novel markers (MPO?) | Hold or stop antineoplastic treatments Start HF therapies |
|
|